ReP USP - Resultado da busca

Artigo de periodico
Paclitaxel associated with cholesterol-rich nanoemulsions promotes atherosclerosis regression in the rabbit (2008)
Maranhão, Raul Cavalcante ; Tavares, Elaine Rufo; Padoveze, Amanda Felippe; Valduga, Claudete Justina; Rodrigues, Debora Garcia; Pereira, Maria das Dores
Source: Atherosclerosis. Unidade: FCF
Subjects: EMULSÕES (FORMAS FARMACÊUTICAS), LIPOPROTEÍNAS LDL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARANHÃO, Raul Cavalcante et al. Paclitaxel associated with cholesterol-rich nanoemulsions promotes atherosclerosis regression in the rabbit. Atherosclerosis, v. 197, n. 2, p. 959-966, 2008Tradução . . Disponível em: https://doi.org/10.1016/j.atherosclerosis.2007.12.051. Acesso em: 16 nov. 2024.
APA
Maranhão, R. C., Tavares, E. R., Padoveze, A. F., Valduga, C. J., Rodrigues, D. G., & Pereira, M. das D. (2008). Paclitaxel associated with cholesterol-rich nanoemulsions promotes atherosclerosis regression in the rabbit. Atherosclerosis, 197( 2), 959-966. doi:10.1016/j.atherosclerosis.2007.12.051
NLM
Maranhão RC, Tavares ER, Padoveze AF, Valduga CJ, Rodrigues DG, Pereira M das D. Paclitaxel associated with cholesterol-rich nanoemulsions promotes atherosclerosis regression in the rabbit [Internet]. Atherosclerosis. 2008 ;197( 2): 959-966.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2007.12.051
Vancouver
Maranhão RC, Tavares ER, Padoveze AF, Valduga CJ, Rodrigues DG, Pereira M das D. Paclitaxel associated with cholesterol-rich nanoemulsions promotes atherosclerosis regression in the rabbit [Internet]. Atherosclerosis. 2008 ;197( 2): 959-966.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2007.12.051
Artigo de periodico
LipoCardium: Endothelium-directed cyclopentenone prostaglandin-based liposome formulation that completely reverses atherosclerotic lesions (2007)
Bittencourt Junior, Paulo Ivo Homem de; Lagranha, Denise Jacques; Maslinkiewicz, Alexandre; Senna, Sueli Moreno; Tavares, Angela Maria Vicente; Baldissera, Lisiane Paula; Janner, Daiane da Rocha; Peralta, Joelso dos Santos; Bock, Patrícia Martins; Gutierrez, Lucila Ludmila Paula; Scola, Gustavo; Heck, Thiago Gomes; Krause, Maurício da Silva; Cruz, Lavínia A.; Abdalla, Dulcinéia Saes Parra ; Lagranha, Claudia Jacques; Lima, Thais; Curi, Rui
Source: Atherosclerosis. Unidades: FCF, ICB
Subjects: ARTERIOSCLEROSE, MACRÓFAGOS, ENDOTÉLIO, LEUCÓCITOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BITTENCOURT JUNIOR, Paulo Ivo Homem de et al. LipoCardium: Endothelium-directed cyclopentenone prostaglandin-based liposome formulation that completely reverses atherosclerotic lesions. Atherosclerosis, v. 193, n. 2, p. 245-258, 2007Tradução . . Disponível em: https://doi.org/10.1016/j.atherosclerosis.2006.08.049. Acesso em: 16 nov. 2024.
APA
Bittencourt Junior, P. I. H. de, Lagranha, D. J., Maslinkiewicz, A., Senna, S. M., Tavares, A. M. V., Baldissera, L. P., et al. (2007). LipoCardium: Endothelium-directed cyclopentenone prostaglandin-based liposome formulation that completely reverses atherosclerotic lesions. Atherosclerosis, 193( 2), 245-258. doi:10.1016/j.atherosclerosis.2006.08.049
NLM
Bittencourt Junior PIH de, Lagranha DJ, Maslinkiewicz A, Senna SM, Tavares AMV, Baldissera LP, Janner D da R, Peralta J dos S, Bock PM, Gutierrez LLP, Scola G, Heck TG, Krause M da S, Cruz LA, Abdalla DSP, Lagranha CJ, Lima T, Curi R. LipoCardium: Endothelium-directed cyclopentenone prostaglandin-based liposome formulation that completely reverses atherosclerotic lesions [Internet]. Atherosclerosis. 2007 ; 193( 2): 245-258.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2006.08.049
Vancouver
Bittencourt Junior PIH de, Lagranha DJ, Maslinkiewicz A, Senna SM, Tavares AMV, Baldissera LP, Janner D da R, Peralta J dos S, Bock PM, Gutierrez LLP, Scola G, Heck TG, Krause M da S, Cruz LA, Abdalla DSP, Lagranha CJ, Lima T, Curi R. LipoCardium: Endothelium-directed cyclopentenone prostaglandin-based liposome formulation that completely reverses atherosclerotic lesions [Internet]. Atherosclerosis. 2007 ; 193( 2): 245-258.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2006.08.049
Artigo de periodico
Identification of mildly oxidized low-density lipoprotein (electronegative LDL) and its auto-antibodies IgG in children and adolescents hypercholesterolemic offsprings (2006)
Barros, Marcos Roberto Andrade Costa; Bertolami, Marcelo Chiara; Abdalla, Dulcinéia Saes Parra ; Ferreira, Waldinai Pereira
Source: Atherosclerosis. Unidade: FCF
Subjects: BIOQUÍMICA CLÍNICA, HIPERCOLESTEROLEMIA, LIPOPROTEÍNAS LDL, ARTERIOSCLEROSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BARROS, Marcos Roberto Andrade Costa et al. Identification of mildly oxidized low-density lipoprotein (electronegative LDL) and its auto-antibodies IgG in children and adolescents hypercholesterolemic offsprings. Atherosclerosis, v. 184, n. 1, p. 103-107, 2006Tradução . . Disponível em: https://doi.org/10.1016/j.atherosclerosis.2004.11.027. Acesso em: 16 nov. 2024.
APA
Barros, M. R. A. C., Bertolami, M. C., Abdalla, D. S. P., & Ferreira, W. P. (2006). Identification of mildly oxidized low-density lipoprotein (electronegative LDL) and its auto-antibodies IgG in children and adolescents hypercholesterolemic offsprings. Atherosclerosis, 184( 1), 103-107. doi:10.1016/j.atherosclerosis.2004.11.027
NLM
Barros MRAC, Bertolami MC, Abdalla DSP, Ferreira WP. Identification of mildly oxidized low-density lipoprotein (electronegative LDL) and its auto-antibodies IgG in children and adolescents hypercholesterolemic offsprings [Internet]. Atherosclerosis. 2006 ; 184( 1): 103-107.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2004.11.027
Vancouver
Barros MRAC, Bertolami MC, Abdalla DSP, Ferreira WP. Identification of mildly oxidized low-density lipoprotein (electronegative LDL) and its auto-antibodies IgG in children and adolescents hypercholesterolemic offsprings [Internet]. Atherosclerosis. 2006 ; 184( 1): 103-107.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2004.11.027
Artigo de periodico
Progesterone abolishes estrogen and/or atorvastatin endothelium dependent vasodilatory effects (2004)
Faludi, André Arpad; Aldrighi, José Mendes; Bertolami, Marcelo Chiara; Saleh, Mohamed H.; Silva, Renata Alves; Nakamura, Yara; Pereira, Isabela Rosier Olimpio; Abdalla, Dulcinéia Saes Parra ; Ramires, José Antônio Franchini; Sousa, José Eduardo M. R.
Source: Atherosclerosis. Unidades: FCF, FSP, FM
Subjects: HIPERCOLESTEROLEMIA, HORMÔNIOS PROGESTACIONAIS, MENOPAUSA, HIPERTENSÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FALUDI, André Arpad et al. Progesterone abolishes estrogen and/or atorvastatin endothelium dependent vasodilatory effects. Atherosclerosis, v. 177, n. 1, p. 89-96, 2004Tradução . . Disponível em: https://doi.org/10.1016/j.atherosclerosis.2004.05.030. Acesso em: 16 nov. 2024.
APA
Faludi, A. A., Aldrighi, J. M., Bertolami, M. C., Saleh, M. H., Silva, R. A., Nakamura, Y., et al. (2004). Progesterone abolishes estrogen and/or atorvastatin endothelium dependent vasodilatory effects. Atherosclerosis, 177( 1), 89-96. doi:10.1016/j.atherosclerosis.2004.05.030
NLM
Faludi AA, Aldrighi JM, Bertolami MC, Saleh MH, Silva RA, Nakamura Y, Pereira IRO, Abdalla DSP, Ramires JAF, Sousa JEMR. Progesterone abolishes estrogen and/or atorvastatin endothelium dependent vasodilatory effects [Internet]. Atherosclerosis. 2004 ; 177( 1): 89-96.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2004.05.030
Vancouver
Faludi AA, Aldrighi JM, Bertolami MC, Saleh MH, Silva RA, Nakamura Y, Pereira IRO, Abdalla DSP, Ramires JAF, Sousa JEMR. Progesterone abolishes estrogen and/or atorvastatin endothelium dependent vasodilatory effects [Internet]. Atherosclerosis. 2004 ; 177( 1): 89-96.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2004.05.030
Artigo de periodico
Atorvastatin enhances the plasma clearance of chylomicron-like emulsions in subjects with atherogenic dyslipidemia: relevance to the in vivo metabolism of triglyceride-rich lipoproteins (2003)
Spósito, Andrei Carvalho; Santos, Raul D.; Amâncio, Rosângela F.; Ramires, José Antônio Franchini; Chapman, M. John; Maranhão, Raul Cavalcante
Source: Atherosclerosis. Unidades: FCF, FM
Subjects: DOENÇAS CARDIOVASCULARES, CARDIOLOGIA, FARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SPÓSITO, Andrei Carvalho et al. Atorvastatin enhances the plasma clearance of chylomicron-like emulsions in subjects with atherogenic dyslipidemia: relevance to the in vivo metabolism of triglyceride-rich lipoproteins. Atherosclerosis, v. 166, n. 2, p. 311-321, 2003Tradução . . Disponível em: https://doi.org/10.1016/s0021-9150(02)00334-9. Acesso em: 16 nov. 2024.
APA
Spósito, A. C., Santos, R. D., Amâncio, R. F., Ramires, J. A. F., Chapman, M. J., & Maranhão, R. C. (2003). Atorvastatin enhances the plasma clearance of chylomicron-like emulsions in subjects with atherogenic dyslipidemia: relevance to the in vivo metabolism of triglyceride-rich lipoproteins. Atherosclerosis, 166( 2), 311-321. doi:10.1016/s0021-9150(02)00334-9
NLM
Spósito AC, Santos RD, Amâncio RF, Ramires JAF, Chapman MJ, Maranhão RC. Atorvastatin enhances the plasma clearance of chylomicron-like emulsions in subjects with atherogenic dyslipidemia: relevance to the in vivo metabolism of triglyceride-rich lipoproteins [Internet]. Atherosclerosis. 2003 ; 166( 2): 311-321.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/s0021-9150(02)00334-9
Vancouver
Spósito AC, Santos RD, Amâncio RF, Ramires JAF, Chapman MJ, Maranhão RC. Atorvastatin enhances the plasma clearance of chylomicron-like emulsions in subjects with atherogenic dyslipidemia: relevance to the in vivo metabolism of triglyceride-rich lipoproteins [Internet]. Atherosclerosis. 2003 ; 166( 2): 311-321.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/s0021-9150(02)00334-9
Artigo de periodico
LDL concentration is correlated with the removal from the plasma of a chylomicron-like emulsion in subjects with coronary artery disease (2002)
Spósito, Andrei Carvalho; Santos, Raul D.; Hueb, Whady; Ventura, Laura Ines; Vinagre, Carmen G. C.; Ramires, José Antônio Franchini; Maranhão, Raul Cavalcante
Source: Atherosclerosis. Unidades: FCF, FM
Subjects: BIOQUÍMICA, PROTEÍNAS (METABOLISMO), HIPERCOLESTEROLEMIA, DOENÇAS CARDIOVASCULARES, PLASMA (CONCENTRAÇÃO)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SPÓSITO, Andrei Carvalho et al. LDL concentration is correlated with the removal from the plasma of a chylomicron-like emulsion in subjects with coronary artery disease. Atherosclerosis, v. 161, n. 2, p. 447-453, 2002Tradução . . Disponível em: https://doi.org/10.1016/s0021-9150(01)00661-x. Acesso em: 16 nov. 2024.
APA
Spósito, A. C., Santos, R. D., Hueb, W., Ventura, L. I., Vinagre, C. G. C., Ramires, J. A. F., & Maranhão, R. C. (2002). LDL concentration is correlated with the removal from the plasma of a chylomicron-like emulsion in subjects with coronary artery disease. Atherosclerosis, 161( 2), 447-453. doi:10.1016/s0021-9150(01)00661-x
NLM
Spósito AC, Santos RD, Hueb W, Ventura LI, Vinagre CGC, Ramires JAF, Maranhão RC. LDL concentration is correlated with the removal from the plasma of a chylomicron-like emulsion in subjects with coronary artery disease [Internet]. Atherosclerosis. 2002 ; 161( 2): 447-453.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/s0021-9150(01)00661-x
Vancouver
Spósito AC, Santos RD, Hueb W, Ventura LI, Vinagre CGC, Ramires JAF, Maranhão RC. LDL concentration is correlated with the removal from the plasma of a chylomicron-like emulsion in subjects with coronary artery disease [Internet]. Atherosclerosis. 2002 ; 161( 2): 447-453.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/s0021-9150(01)00661-x
Artigo de periodico
Effects of etofibrate upon the metabolism of chylomicron-like emulsions in patients with coronary artery disease (2001)
Spósito, Andrei Carvalho; Maranhão, Raul Cavalcante ; Vinagre, Carmen G. C.; Santos, Raul D.; Ramires, José Antônio Franchini
Source: Atherosclerosis. Unidades: FCF, FM
Assunto: CARDIOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SPÓSITO, Andrei Carvalho et al. Effects of etofibrate upon the metabolism of chylomicron-like emulsions in patients with coronary artery disease. Atherosclerosis, v. 154, n. 2, p. 455-461, 2001Tradução . . Disponível em: https://doi.org/10.1016/s0021-9150(00)00491-3. Acesso em: 16 nov. 2024.
APA
Spósito, A. C., Maranhão, R. C., Vinagre, C. G. C., Santos, R. D., & Ramires, J. A. F. (2001). Effects of etofibrate upon the metabolism of chylomicron-like emulsions in patients with coronary artery disease. Atherosclerosis, 154( 2), 455-461. doi:10.1016/s0021-9150(00)00491-3
NLM
Spósito AC, Maranhão RC, Vinagre CGC, Santos RD, Ramires JAF. Effects of etofibrate upon the metabolism of chylomicron-like emulsions in patients with coronary artery disease [Internet]. Atherosclerosis. 2001 ; 154( 2): 455-461.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/s0021-9150(00)00491-3
Vancouver
Spósito AC, Maranhão RC, Vinagre CGC, Santos RD, Ramires JAF. Effects of etofibrate upon the metabolism of chylomicron-like emulsions in patients with coronary artery disease [Internet]. Atherosclerosis. 2001 ; 154( 2): 455-461.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/s0021-9150(00)00491-3

USP Schools

ReP

Filtros

Authors

Date published

Subjects

Indexado em

Non normalized affiliation